Emtricitabine/tenofovir-disoproxil-fumarate/raltegravirNausea: case report

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2019年 / 1734卷 / 1期

关键词：

D O I：

10.1007/s40278-019-56326-7

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：201 / 201

相关论文

共 50 条

[1] Emtricitabine/tenofovir-disoproxil-fumarate/pembrolizumabPulmonary toxicity and osteoporosis: case report
[J]. Reactions Weekly, 2023, 1975 (1) : 159 - 159
[2] Elvitegravir/emtricitabine/tenofovir-disoproxil-fumarate/cobicistatRenal tubulopathy: case report
[J]. Reactions Weekly, 2017, 1633 (1) : 301 - 301
[3] Efavirenz/emtricitabine/tenofovir-disoproxil-fumarate/phenytoinVarious toxicities: case report
[J]. Reactions Weekly, 2018, 1706 (1) : 187 - 187
[4] Emtricitabine/tenofovir-disoproxil-fumarate/raltegravirLack of efficacy
[J]. Reactions Weekly, 2024, 2016 (1) : 182 - 182
[5] Budesonide/emtricitabine/rilpivirine/tenofovir-disoproxil-fumarate interactionCushing Syndrome: case report
[J]. Reactions Weekly, 2020, 1810 (1) : 57 - 57
[6] Elvitegravir/emtricitabine/tenofovir-disoproxil-fumarate/cobicistat/sildenafil interactionHypotension: case report
[J]. Reactions Weekly, 2020, 1788 (1) : 104 - 104
[7] Emtricitabine/tenofovir-disoproxil-fumarate/lopinavir/ritonavirHumeral aseptic osteonecrosis: case report
[J]. Reactions Weekly, 2022, 1889 (1) : 147 - 147
[8] Elvitegravir/emtricitabine/tenofovir-disoproxil-fumarate/cobicistatPartial proximal tubulopathy: case report
[J]. Reactions Weekly, 2017, 1667 (1) : 137 - 137
[9] Elvitegravir/emtricitabine/tenofovir-disoproxil-fumarate/cobicistatImmune reconstitution inflammatory syndrome: case report
[J]. Reactions Weekly, 2023, 1956 (1) : 213 - 213
[10] Darunavir and elvitegravir/emtricitabine/tenofovir-disoproxil-fumarate/cobicistatIncreased serum creatinine: case report
[J]. Reactions Weekly, 2019, 1736 (1) : 82 - 82

← 1 2 3 4 5 →